<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>neurology</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>neurology | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="Striatal dopamine tone is positively associated with body mass index in humans as determined by PET using dual dopamine type-2 receptor antagonist tracers
Authors: Darcey, V. L.; Guo, J.; Chi, M.; Chung, S. T.; Courville, A. B.; Gallagher, I.; Herscovitch, P.; Howard, R.; La Noire, M.; Milley, L.; Schick, A.; Stagliano, M.; Turner, S.; Urbanski, N.; Yang, S.; Yim, E.; Zhai, N.; Zhou, M. S.; Hall, K. D.
Score: 45.">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/neurology/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="neurology" />
<meta property="og:description" content="Striatal dopamine tone is positively associated with body mass index in humans as determined by PET using dual dopamine type-2 receptor antagonist tracers
Authors: Darcey, V. L.; Guo, J.; Chi, M.; Chung, S. T.; Courville, A. B.; Gallagher, I.; Herscovitch, P.; Howard, R.; La Noire, M.; Milley, L.; Schick, A.; Stagliano, M.; Turner, S.; Urbanski, N.; Yang, S.; Yim, E.; Zhai, N.; Zhou, M. S.; Hall, K. D.
Score: 45." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/neurology/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2023-10-08T10:37:16+00:00" />
<meta property="article:modified_time" content="2023-10-08T10:37:16+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="neurology"/>
<meta name="twitter:description" content="Striatal dopamine tone is positively associated with body mass index in humans as determined by PET using dual dopamine type-2 receptor antagonist tracers
Authors: Darcey, V. L.; Guo, J.; Chi, M.; Chung, S. T.; Courville, A. B.; Gallagher, I.; Herscovitch, P.; Howard, R.; La Noire, M.; Milley, L.; Schick, A.; Stagliano, M.; Turner, S.; Urbanski, N.; Yang, S.; Yim, E.; Zhai, N.; Zhou, M. S.; Hall, K. D.
Score: 45."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "neurology",
      "item": "https://trxiv.yorks0n.com/posts/neurology/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "neurology",
  "name": "neurology",
  "description": "Striatal dopamine tone is positively associated with body mass index in humans as determined by PET using dual dopamine type-2 receptor antagonist tracers\nAuthors: Darcey, V. L.; Guo, J.; Chi, M.; Chung, S. T.; Courville, A. B.; Gallagher, I.; Herscovitch, P.; Howard, R.; La Noire, M.; Milley, L.; Schick, A.; Stagliano, M.; Turner, S.; Urbanski, N.; Yang, S.; Yim, E.; Zhai, N.; Zhou, M. S.; Hall, K. D.\nScore: 45.",
  "keywords": [
    
  ],
  "articleBody": " Striatal dopamine tone is positively associated with body mass index in humans as determined by PET using dual dopamine type-2 receptor antagonist tracers\nAuthors: Darcey, V. L.; Guo, J.; Chi, M.; Chung, S. T.; Courville, A. B.; Gallagher, I.; Herscovitch, P.; Howard, R.; La Noire, M.; Milley, L.; Schick, A.; Stagliano, M.; Turner, S.; Urbanski, N.; Yang, S.; Yim, E.; Zhai, N.; Zhou, M. S.; Hall, K. D.\nScore: 45.2, Published: 2023-09-28 DOI: 10.1101/2023.09.27.23296169\nThe relationship between adiposity and dopamine type-2 receptor binding potential (D2BP) in the human brain has been repeatedly studied for \u003e20 years with highly discrepant results, likely due to variable methodologies and differing study populations. We conducted a controlled inpatient feeding study to measure D2BP in the striatum using positron emission tomography with both [18F]fallypride and [11C]raclopride in pseudo-random order in 54 young adults with a wide range of body mass index (BMI 20-44 kg/m2). Within-subject D2BP measurements using the two tracers were moderately correlated (r=0.47, p\u003c0.001). D2BP was negatively correlated with BMI as measured by [11C]raclopride (r= -0.51; p\u003c0.0001) but not [18F]fallypride (r=-0.01; p=0.92) and these correlation coefficients were significantly different from each other (p\u003c0.001). Given that [18F]fallypride has greater binding affinity to dopamine type-2 receptors than [11C]raclopride, which is more easily displaced by endogenous dopamine, our results suggest that adiposity is positively associated with increased striatal dopamine tone.\nRare variation in noncoding regions with evolutionary signatures contributes to autism spectrum disorder risk\nAuthors: Shin, T.; Song, J. H.; Kosicki, M.; Kenny, C.; Beck, S. G.; Kelley, L.; Qian, X.; Bonacina, J.; Papandile, F.; Antony, I.; Gonzalez, D.; Scotellaro, J.; Bushinsky, E. M.; Andersen, R. E.; Maury, E. A.; Pennacchio, L. A.; Doan, R. N.; Walsh, C. A.\nScore: 12.7, Published: 2023-09-22 DOI: 10.1101/2023.09.19.23295780\nLittle is known about the role of noncoding regions in the etiology of autism spectrum disorder (ASD). We examined three classes of noncoding regions: Human Accelerated Regions (HARs), which show signatures of positive selection in humans; experimentally validated neural Vista Enhancers (VEs); and conserved regions predicted to act as neural enhancers (CNEs). Targeted and whole genome analysis of \u003e16,600 samples and \u003e4900 ASD probands revealed that likely recessive, rare, inherited variants in HARs, VEs, and CNEs substantially contribute to ASD risk in probands whose parents share ancestry, which enriches for recessive contributions, but modestly, if at all, in simplex family structures. We identified multiple patient variants in HARs near IL1RAPL1 and in a VE near SIM1 and showed that they change enhancer activity. Our results implicate both human-evolved and evolutionarily conserved noncoding regions in ASD risk and suggest potential mechanisms of how changes in regulatory regions can modulate social behavior.\nCharacterization of baseline and longitudinal DNA Methylation in patients with sporadic Parkinsons disease\nAuthors: Gonzalez-Latapi, P.; Bustos, B. I.; Dong, S.; Lubbe, S.; Simuni, T.; Krainc, D.\nScore: 1.1, Published: 2023-10-02 DOI: 10.1101/2023.09.28.23296098\nObjectiveTo characterize DNA methylation differences between sporadic Parkinsons Disease and healthy control individuals enrolled in the Parkinsons Progression Markers Initiative. MethodsWe characterized cross-sectional and longitudinal DNA methylation differences between individuals with sporadic (i.e., non-genetic) PD and healthy controls. We included 282 individuals (196 Parkinsons Disease individuals and 86 healthy control individuals). DNA methylation data was collected at the time of enrollment and longitudinally over three years. ResultsThis analysis revealed 81,604 differentially methylated positions and 5,281 differentially methylated regions between sporadic PD and healthy controls. Gene ontology analysis revealed that these differentially methylated positions and regions were associated with genes involved in diverse cellular processes, including several with specific functions in the brain (Focal adhesion\", \"Cholinergic synapse\", \"Glutamatergic synapse\", \"Dopaminergic synapse\"). Integration of both differentially methylated sites and expressed genes showed 20 genes that were hypomethylated and overexpressed and one gene, CTSH that was hypermethylated and associated with reduced expression. Interpretation of ResultsOur study provides evidence that alterations in the methylome in Parkinsons Disease are discernible in blood, evolve over time, and reflect cellular processes linked to ongoing neurodegeneration. These findings lend support to the potential of blood DNA methylation as an epigenetic biomarker for Parkinsons Disease. To fully comprehend DNA methylation changes throughout the progression of Parkinsons Disease, additional profiling at longer intervals and during the prodromal stage will be necessary.\nAn unsupervised machine learning approach to predict recovery from traumatic spinal cord injury\nAuthors: Brueningk, S. C.; Bourguignon, L.; Lukas, L.; EMSCI Study Group, ; Maier, D.; Abel, R.; Weidner, N.; Rupp, R.; Geisler, F.; Kramer, J. L. K.; Guest, J.; Curt, A.; Jutzeler, C. R.\nScore: 1.2, Published: 2023-09-26 DOI: 10.1101/2023.09.26.23295361\nBackgroundNeurological and functional recovery after traumatic spinal cord injury (SCI) is highly heterogeneous, challenging outcome predictions in rehabilitation and clinical trials. We propose k-nearest neighbour (k-NN) matching as a data-driven, interpretable solution. MethodsThis study used acute-phase International Standards for Neurological Classification of SCI exams to forecast 6-month recovery motor function as primary evaluation endpoint. Secondary endpoints included severity grade improvement, independent walking, and self-care ability. Different similarity metrics were explored for NN matching within 1267 patients from the European Multicenter Study about Spinal Cord Injury before validation in 411 patients from the Sygen trial. ResultsWe obtained a population-wide root-mean-squared error (RMSE) in motor score sequence of 0.76(0.14, 2.77) and competitive functional score predictions (AUCwalker=0.92, AUCself-carer=0.83). The validation cohort showed comparable results (RMSE = 0.75(0.13, 2.57), AUCwalker=0.92). Prediction performance in AIS grade B and C patients ([~]30%) showed the largest deviations from true recovery scores, in line with large SCI heterogeneity. ConclusionsOur approach provides detailed predictions of neurological and functional recovery based on a highly interpretable unsupervised machine learning concept. The k-NN matching strategy further enables the integration of historical control data into the evaluation of clinical trials and provides a data-driven digital twin for recovery trajectory exploration.\n",
  "wordCount" : "942",
  "inLanguage": "en",
  "datePublished": "2023-10-08T10:37:16Z",
  "dateModified": "2023-10-08T10:37:16Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/neurology/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      neurology
    </h1>
    <div class="post-meta"><span>updated on October 8, 2023</span>

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.09.27.23296169">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.09.27.23296169" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.09.27.23296169">
        <p class="paperTitle">Striatal dopamine tone is positively associated with body mass index in humans as determined by PET using dual dopamine type-2 receptor antagonist tracers</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.09.27.23296169" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.09.27.23296169" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Darcey, V. L.; Guo, J.; Chi, M.; Chung, S. T.; Courville, A. B.; Gallagher, I.; Herscovitch, P.; Howard, R.; La Noire, M.; Milley, L.; Schick, A.; Stagliano, M.; Turner, S.; Urbanski, N.; Yang, S.; Yim, E.; Zhai, N.; Zhou, M. S.; Hall, K. D.</p>
        <p class="info">Score: 45.2, Published: 2023-09-28 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.09.27.23296169' target='https://doi.org/10.1101/2023.09.27.23296169'> 10.1101/2023.09.27.23296169</a></p>
        <p class="abstract">The relationship between adiposity and dopamine type-2 receptor binding potential (D2BP) in the human brain has been repeatedly studied for &gt;20 years with highly discrepant results, likely due to variable methodologies and differing study populations. We conducted a controlled inpatient feeding study to measure D2BP in the striatum using positron emission tomography with both [18F]fallypride and [11C]raclopride in pseudo-random order in 54 young adults with a wide range of body mass index (BMI 20-44 kg/m2). Within-subject D2BP measurements using the two tracers were moderately correlated (r=0.47, p&lt;0.001). D2BP was negatively correlated with BMI as measured by [11C]raclopride (r= -0.51; p&lt;0.0001) but not [18F]fallypride (r=-0.01; p=0.92) and these correlation coefficients were significantly different from each other (p&lt;0.001). Given that [18F]fallypride has greater binding affinity to dopamine type-2 receptors than [11C]raclopride, which is more easily displaced by endogenous dopamine, our results suggest that adiposity is positively associated with increased striatal dopamine tone.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.09.19.23295780">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.09.19.23295780" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.09.19.23295780">
        <p class="paperTitle">Rare variation in noncoding regions with evolutionary signatures contributes to autism spectrum disorder risk</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.09.19.23295780" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.09.19.23295780" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Shin, T.; Song, J. H.; Kosicki, M.; Kenny, C.; Beck, S. G.; Kelley, L.; Qian, X.; Bonacina, J.; Papandile, F.; Antony, I.; Gonzalez, D.; Scotellaro, J.; Bushinsky, E. M.; Andersen, R. E.; Maury, E. A.; Pennacchio, L. A.; Doan, R. N.; Walsh, C. A.</p>
        <p class="info">Score: 12.7, Published: 2023-09-22 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.09.19.23295780' target='https://doi.org/10.1101/2023.09.19.23295780'> 10.1101/2023.09.19.23295780</a></p>
        <p class="abstract">Little is known about the role of noncoding regions in the etiology of autism spectrum disorder (ASD). We examined three classes of noncoding regions: Human Accelerated Regions (HARs), which show signatures of positive selection in humans; experimentally validated neural Vista Enhancers (VEs); and conserved regions predicted to act as neural enhancers (CNEs). Targeted and whole genome analysis of &gt;16,600 samples and &gt;4900 ASD probands revealed that likely recessive, rare, inherited variants in HARs, VEs, and CNEs substantially contribute to ASD risk in probands whose parents share ancestry, which enriches for recessive contributions, but modestly, if at all, in simplex family structures. We identified multiple patient variants in HARs near IL1RAPL1 and in a VE near SIM1 and showed that they change enhancer activity. Our results implicate both human-evolved and evolutionarily conserved noncoding regions in ASD risk and suggest potential mechanisms of how changes in regulatory regions can modulate social behavior.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.09.28.23296098">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.09.28.23296098" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.09.28.23296098">
        <p class="paperTitle">Characterization of baseline and longitudinal DNA Methylation in patients with sporadic Parkinsons disease</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.09.28.23296098" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.09.28.23296098" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Gonzalez-Latapi, P.; Bustos, B. I.; Dong, S.; Lubbe, S.; Simuni, T.; Krainc, D.</p>
        <p class="info">Score: 1.1, Published: 2023-10-02 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.09.28.23296098' target='https://doi.org/10.1101/2023.09.28.23296098'> 10.1101/2023.09.28.23296098</a></p>
        <p class="abstract">ObjectiveTo characterize DNA methylation differences between sporadic Parkinsons Disease and healthy control individuals enrolled in the Parkinsons Progression Markers Initiative.

MethodsWe characterized cross-sectional and longitudinal DNA methylation differences between individuals with sporadic (i.e., non-genetic) PD and healthy controls. We included 282 individuals (196 Parkinsons Disease individuals and 86 healthy control individuals). DNA methylation data was collected at the time of enrollment and longitudinally over three years.

ResultsThis analysis revealed 81,604 differentially methylated positions and 5,281 differentially methylated regions between sporadic PD and healthy controls. Gene ontology analysis revealed that these differentially methylated positions and regions were associated with genes involved in diverse cellular processes, including several with specific functions in the brain (Focal adhesion&#34;, &#34;Cholinergic synapse&#34;, &#34;Glutamatergic synapse&#34;, &#34;Dopaminergic synapse&#34;). Integration of both differentially methylated sites and expressed genes showed 20 genes that were hypomethylated and overexpressed and one gene, CTSH that was hypermethylated and associated with reduced expression.

Interpretation of ResultsOur study provides evidence that alterations in the methylome in Parkinsons Disease are discernible in blood, evolve over time, and reflect cellular processes linked to ongoing neurodegeneration. These findings lend support to the potential of blood DNA methylation as an epigenetic biomarker for Parkinsons Disease. To fully comprehend DNA methylation changes throughout the progression of Parkinsons Disease, additional profiling at longer intervals and during the prodromal stage will be necessary.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.09.26.23295361">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.09.26.23295361" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.09.26.23295361">
        <p class="paperTitle">An unsupervised machine learning approach to predict recovery from traumatic spinal cord injury</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.09.26.23295361" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.09.26.23295361" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Brueningk, S. C.; Bourguignon, L.; Lukas, L.; EMSCI Study Group,  ; Maier, D.; Abel, R.; Weidner, N.; Rupp, R.; Geisler, F.; Kramer, J. L. K.; Guest, J.; Curt, A.; Jutzeler, C. R.</p>
        <p class="info">Score: 1.2, Published: 2023-09-26 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.09.26.23295361' target='https://doi.org/10.1101/2023.09.26.23295361'> 10.1101/2023.09.26.23295361</a></p>
        <p class="abstract">BackgroundNeurological and functional recovery after traumatic spinal cord injury (SCI) is highly heterogeneous, challenging outcome predictions in rehabilitation and clinical trials. We propose k-nearest neighbour (k-NN) matching as a data-driven, interpretable solution.

MethodsThis study used acute-phase International Standards for Neurological Classification of SCI exams to forecast 6-month recovery motor function as primary evaluation endpoint. Secondary endpoints included severity grade improvement, independent walking, and self-care ability. Different similarity metrics were explored for NN matching within 1267 patients from the European Multicenter Study about Spinal Cord Injury before validation in 411 patients from the Sygen trial.

ResultsWe obtained a population-wide root-mean-squared error (RMSE) in motor score sequence of 0.76(0.14, 2.77) and competitive functional score predictions (AUCwalker=0.92, AUCself-carer=0.83). The validation cohort showed comparable results (RMSE = 0.75(0.13, 2.57), AUCwalker=0.92). Prediction performance in AIS grade B and C patients ([~]30%) showed the largest deviations from true recovery scores, in line with large SCI heterogeneity.

ConclusionsOur approach provides detailed predictions of neurological and functional recovery based on a highly interpretable unsupervised machine learning concept. The k-NN matching strategy further enables the integration of historical control data into the evaluation of clinical trials and provides a data-driven digital twin for recovery trajectory exploration.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2023 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        Â· Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
